RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,180,000 | +5.4% | 65,991 | +43.8% | 0.08% | +14.9% |
| Q2 2021 | $1,120,000 | +162.3% | 45,892 | +184.7% | 0.07% | +138.7% |
| Q1 2021 | $427,000 | +145.4% | 16,120 | -29.6% | 0.03% | +158.3% |
| Q4 2020 | $174,000 | -29.8% | 22,912 | -53.7% | 0.01% | -25.0% |
| Q3 2020 | $248,000 | -30.5% | 49,500 | -17.1% | 0.02% | -33.3% |
| Q2 2020 | $357,000 | – | 59,742 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |